OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Biomarkers for response in major depression: comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies
Lucia Carboni, Dennis J. McCarthy, Bruno Delafont, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 65
Lucia Carboni, Dennis J. McCarthy, Bruno Delafont, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 65
Showing 51-75 of 65 citing articles:
<p>Dual Metabolomic Platforms Identified a Novel Urinary Metabolite Signature for Hepatitis B Virus-Infected Patients with Depression</p>
Jing Xie, Chang Chen, Lijuan Hou, et al.
Diabetes Metabolic Syndrome and Obesity (2020) Vol. Volume 13, pp. 1677-1683
Open Access | Times Cited: 5
Jing Xie, Chang Chen, Lijuan Hou, et al.
Diabetes Metabolic Syndrome and Obesity (2020) Vol. Volume 13, pp. 1677-1683
Open Access | Times Cited: 5
CYP2C19 polymorphisms are associated with severity of depression at initial evaluation and after the treatment independently of the prescribed medications: 4 weeks prospective study
Robertas Strumila, Aistė Lengvenytė, Laima Ambrozaitytė, et al.
Psychiatric Genetics (2021) Vol. 31, Iss. 5, pp. 177-185
Closed Access | Times Cited: 5
Robertas Strumila, Aistė Lengvenytė, Laima Ambrozaitytė, et al.
Psychiatric Genetics (2021) Vol. 31, Iss. 5, pp. 177-185
Closed Access | Times Cited: 5
Pharmacogenomic biomarkers as source of evidence of the effectiveness and safety of antidepressant therapy
Catarina F. Correia, Luciano Alcobia, Manuel José Lopes, et al.
BMC Psychiatry (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Catarina F. Correia, Luciano Alcobia, Manuel José Lopes, et al.
BMC Psychiatry (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Effects of paroxetine hydrochloride combined with idebenone on inflammatory factors and antioxidant molecules in treatment of depression after ischemic stroke
Lili Yuan, Tianyu Chen, Zhiqiang Huang
Pakistan Journal of Medical Sciences (2022) Vol. 39, Iss. 1
Open Access | Times Cited: 3
Lili Yuan, Tianyu Chen, Zhiqiang Huang
Pakistan Journal of Medical Sciences (2022) Vol. 39, Iss. 1
Open Access | Times Cited: 3
Low-dose interleukin 2 antidepressant potentiation in unipolar and bipolar depression: Safety, efficacy, and immunological biomarkers
Sara Poletti, Raffaella Zanardi, Alessandra Mandelli, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Sara Poletti, Raffaella Zanardi, Alessandra Mandelli, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Correlations between major depressive disorder, splenic morphology and immunity
Zouqing Lin, Xiaoyan Xu, Kai Zhang, et al.
Research Square (Research Square) (2024)
Closed Access
Zouqing Lin, Xiaoyan Xu, Kai Zhang, et al.
Research Square (Research Square) (2024)
Closed Access
Bulk serum extracellular vesicles from stressed mice show a distinct proteome and induce behavioral and molecular changes in naive mice
Melisa C. Monteleone, Silvia Billi, Lorena Abarzúa-Catalán, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0308976-e0308976
Open Access
Melisa C. Monteleone, Silvia Billi, Lorena Abarzúa-Catalán, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0308976-e0308976
Open Access
Potential cardioprotective effect of paroxetine against ventricular remodeling in an animal model of myocardial infarction: a comparative study
Asma S. Alonazi, Sara Almodawah, Rana Aldigi, et al.
BMC Pharmacology and Toxicology (2024) Vol. 25, Iss. 1
Open Access
Asma S. Alonazi, Sara Almodawah, Rana Aldigi, et al.
BMC Pharmacology and Toxicology (2024) Vol. 25, Iss. 1
Open Access
Enhancing predictive accuracy for antidepressant response in depressive disorders: The additive value of interleukin-1β and interleukin-6 alongside hsCRP
Jae‐Min Kim, Hee‐Ju Kang, Ju‐Wan Kim, et al.
Journal of Affective Disorders (2024) Vol. 373, pp. 94-98
Closed Access
Jae‐Min Kim, Hee‐Ju Kang, Ju‐Wan Kim, et al.
Journal of Affective Disorders (2024) Vol. 373, pp. 94-98
Closed Access
Folate metabolism biomarkers from two randomised placebo-controlled clinical studies with paroxetine and venlafaxine
Lucia Carboni, Bruno Delafont, E. Yu. Ivanchenko, et al.
The World Journal of Biological Psychiatry (2020) Vol. 22, Iss. 4, pp. 315-321
Open Access | Times Cited: 1
Lucia Carboni, Bruno Delafont, E. Yu. Ivanchenko, et al.
The World Journal of Biological Psychiatry (2020) Vol. 22, Iss. 4, pp. 315-321
Open Access | Times Cited: 1
Cytokines as Biomarkers in Psychiatric Disorders: Methodological Issues
Olfa Khalfallah, Susana Barbosa, Emanuela Martinuzzi, et al.
Springer eBooks (2021), pp. 67-83
Closed Access | Times Cited: 1
Olfa Khalfallah, Susana Barbosa, Emanuela Martinuzzi, et al.
Springer eBooks (2021), pp. 67-83
Closed Access | Times Cited: 1
Use of Serum Biomarkers to Aid Antidepressant Selection in Depressive Patients
Hee‐Ju Kang, Ju‐Wan Kim, Wonsuk Choi, et al.
Clinical Psychopharmacology and Neuroscience (2023) Vol. 22, Iss. 1, pp. 182-187
Open Access
Hee‐Ju Kang, Ju‐Wan Kim, Wonsuk Choi, et al.
Clinical Psychopharmacology and Neuroscience (2023) Vol. 22, Iss. 1, pp. 182-187
Open Access
C-Reactive Protein As A Response Indicator In Drug-Naïve Patients With Major Depressive Disorder: A Hospital-Based Study
Ather Muneer, Nargis Munir, Nadia Shams, et al.
Journal of Rawalpindi Medical College (2023) Vol. 27, Iss. 4
Open Access
Ather Muneer, Nargis Munir, Nadia Shams, et al.
Journal of Rawalpindi Medical College (2023) Vol. 27, Iss. 4
Open Access
O PAPEL DA IL-10 E SEU -819 C>T (rs1800871) NO DESENVOLVIMENTO DAS DOENÇAS PSIQUIÁTRICAS
Letícia Henrique Leite da Silva, Pedró José Rolim Neto, Bruna Brandão dos Santos, et al.
(2023) Vol. 12, Iss. 14
Closed Access
Letícia Henrique Leite da Silva, Pedró José Rolim Neto, Bruna Brandão dos Santos, et al.
(2023) Vol. 12, Iss. 14
Closed Access
Identification of Statin’s Action in a Small Cohort of Patients with Major Depression
Ishani Thakkar, Teresa Massardo, Jaime Pereira, et al.
Applied Sciences (2021) Vol. 11, Iss. 6, pp. 2827-2827
Open Access
Ishani Thakkar, Teresa Massardo, Jaime Pereira, et al.
Applied Sciences (2021) Vol. 11, Iss. 6, pp. 2827-2827
Open Access
Immunoregulatory effects of paroxetine in healthy volunteers: An in vitro investigation
Alireza Karimollah, Anahid Hemmatpur, Maryam Asadi, et al.
Journal of Reports in Pharmaceutical Sciences (2021) Vol. 10, Iss. 1, pp. 118-118
Closed Access
Alireza Karimollah, Anahid Hemmatpur, Maryam Asadi, et al.
Journal of Reports in Pharmaceutical Sciences (2021) Vol. 10, Iss. 1, pp. 118-118
Closed Access
“Golden Shot” in the Treatment and Diagnosis of Schizophrenia: Psychiatrists or Neuroscientists?
Irina Vladimirovna Dubatova, Lema Andreevich Antsyborov, Artur Fedorovich Kheigetian, et al.
Interactive science (2021), Iss. 10 (65), pp. 9-24
Open Access
Irina Vladimirovna Dubatova, Lema Andreevich Antsyborov, Artur Fedorovich Kheigetian, et al.
Interactive science (2021), Iss. 10 (65), pp. 9-24
Open Access
